Wilmington, DE, United States of America

Rene Arentzen


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Rene Arentzen**

Introduction

Rene Arentzen, based in Wilmington, DE, is a distinguished inventor recognized for her innovative contributions in the field of biomolecule immobilization. With a total of three patents to her name, she has made significant strides in the development of technologies that enhance the efficiency of biomolecule applications.

Latest Patents

Rene's latest patents revolve around the immobilization of biomolecules on fluorocarbon surfaces using poly(fluoroalkyl) sugar reagents. Her innovative work includes the formulation of these reagents, which contain sugar molecules such as monosaccharides and disaccharides bonded to fluoroalkyl anchor groups. These groups allow for effective attachment to fluorocarbon surfaces and carry reactive groups for covalent coupling with biomolecules such as enzymes. Additionally, the reagents can feature charged or non-ionic groups to enhance their functionality, facilitating applications in heterogeneous diagnostic assays and biosensor preparation.

Career Highlights

Throughout her career, Rene has been associated with E.I. du Pont de Nemours and Company, a major player in the chemical industry. Her expertise in the field of biomolecules has led to innovative discoveries that may further the development of biosensors and advancements in medical diagnostics.

Collaborations

Rene collaborates with notable colleagues, including Prabhakar Kondaji Jadhav and Robert K. Kobos. These professional relationships highlight her ability to work effectively within a team environment, converging diverse expertise to push the boundaries of innovation in her field.

Conclusion

Rene Arentzen stands out as a remarkable inventor whose patents significantly impact the realm of biomolecule immobilization. Her ongoing work with E.I. du Pont de Nemours and Company and her collaborations with esteemed colleagues pave the way for future breakthroughs in biotechnological applications. As the world increasingly relies on advanced diagnostic methods, her contributions remain crucial in shaping efficient and innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…